Study on the path of new quality productivity to promote high quality development of drug regulation
YUAN Yanfang
Abstract：General Secretary Xi Jinping's series of important expositions and major deployments on new quality productivity have provided a basic guideline for the high-quality development of drug regulation.This paper focused on the development path of new quality productivity in China's drug regulation.At present,China's drug innovation in some tracks has realized the change from running behind to running in parallel,and the renewal of the structure of the pharmaceutical industry has accelerated,hence the characteristics of the new quality productivity of the drug regulatory object are gradually unfolding.The main factors driving the new quality productivity of drug regulation are laborers and labor tools,and that means the regulatory personnel and regulatory tools.Existing problems include a large shortage of high-quality regulatory personnel;Traditional regulatory tools are difficult to meet the demand;And a smart regulatory model has not yet been fully established.Accordingly,specific measures are proposed to cultivate innovative talents in regulatory science in the new era,accelerate the innovation of drug regulatory tools and promote the innovation of drug regulatory models,with a view to accelerating the development of new quality productivity in drug regulation and contributing to the high-quality development of drug regulation.
Keywords：New quality productivityDrug regulationInnovation
Publication Date：2025-02-27
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 145-149 )